Skip to content
Screener

Lifecore Biomedical, Inc. LFCR Q4 2026 earnings

Reported May 6, 2026 · Before market open

Revenue$23.2M
EPS-$0.43Miss by $0.19
EPS estimate-$0.24

Next report

Date not yet announced

Financials

Q4 2026

Income statement

See full
Revenue$23.2M-36.4%
Gross profit$4.5M-68.1%
Operating income-$4.7M-188%
Net income-$15.0M-1,206%
EPS (diluted)-$0.43-617%

Balance sheet

See full
Cash & equivalents$20.8M+152%
Total debt$156.9M+1,310%
Total equity-$28.4M-2,229%
Total assets$225.5M-5.8%

Cash flow

See full
Operating cash flow$4.7M-61.2%
CapEx$1.1M-46.7%
Free cash flow$3.6M—

Valuation & ratios

Valuation

as of 05/29/26
See full
Market cap$188.3M-27.3%
Enterprise value$324.44M+23.8%

Returns & leverage

See full
Current ratio3.8×+0.9×

Segments

By product

See full
CDMO$15.8M-32.9%
HA manufacturing$7.4M-42.6%

By segment

See full
Reportable Segment$23.2M-36.4%

FAQ

When did Lifecore Biomedical, Inc. report Q4 2026 earnings?
Lifecore Biomedical, Inc. (LFCR) reported Q4 2026 earnings on May 6, 2026 before market open.
What were Lifecore Biomedical, Inc.'s Q4 2026 revenue and EPS?
Lifecore Biomedical, Inc. reported revenue of $23.2M and eps of $-0.43 for Q4 2026.
Did Lifecore Biomedical, Inc. beat estimates in Q4 2026?
EPS missed the consensus estimate of $-0.24 by $0.19.
How did Lifecore Biomedical, Inc.'s Q4 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 36.4% from $36.4M a year earlier and eps declined 330.0% from $-0.10.
Where can I find Lifecore Biomedical, Inc.'s Q4 2026 SEC filings?
You can read the 8-K earnings release (0001005286-26-000018) and the 10-Q periodic report (0001005286-26-000033) directly on SEC EDGAR. The filing index links above go to sec.gov.